Free Trial
NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.02
$1.06
50-Day Range
N/A
52-Week Range
$47.02
$64.78
Volume
219,275 shs
Average Volume
755,161 shs
Market Capitalization
$31.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

(ANTX) MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
92.3% Upside
$2.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of (ANTX) in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$3.81 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.94) to ($1.53) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.17 out of 5 stars

Medical Sector

558th out of 927 stocks

Pharmaceutical Preparations Industry

257th out of 425 stocks

ANTX stock logo

About (ANTX) Stock (NYSE:ANTX)

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

ANTX Stock News Headlines

I want to be very real with you
Listen, I don’t come at my readers this direct very often, but here goes nothing: There is one strategy that has helped change my life and I’d like to think it has changed the lives of some of my readers, too. We’ve had success stories but I won’t even show you here because I don’t want you to get unrealistic expectations since individual results do vary. But the point is, this thing is the real deal. There’s a reason I consider it my flagship, even with all the market advantages I’ve discovered in recent years.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024
Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?
I want to be very real with you
Listen, I don’t come at my readers this direct very often, but here goes nothing: There is one strategy that has helped change my life and I’d like to think it has changed the lives of some of my readers, too. We’ve had success stories but I won’t even show you here because I don’t want you to get unrealistic expectations since individual results do vary. But the point is, this thing is the real deal. There’s a reason I consider it my flagship, even with all the market advantages I’ve discovered in recent years.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023
AN2 Therapeutics just downgraded at Evercore ISI, here's why
See More Headlines
Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2024
Today
9/16/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Previous Symbol
NASDAQ:ANTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+92.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-64,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.19 per share

Miscellaneous

Free Float
23,628,000
Market Cap
$31.03 million
Optionable
Not Optionable
Beta
-0.21
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Joseph R. Swedish (Age 66)
    Exec. Chairman
  • Ms. Gail Koziara Boudreaux (Age 57)
    Pres, CEO & Director
  • Mr. John Edward Gallina (Age 58)
    Exec. VP & CFO
  • Ms. Gloria Marie McCarthy (Age 65)
    Exec. VP and Chief Admin. & Transformation Officer
  • Mr. Peter David Haytaian (Age 48)
    Exec. VP & Pres of Commercial and Specialty Bus. Division

ANTX Stock Analysis - Frequently Asked Questions

How were (ANTX)'s earnings last quarter?

(ANTX) (NYSE:ANTX) issued its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.48) EPS for the quarter, topping the consensus estimate of ($0.59) by $0.11.

When did (ANTX) IPO?

(ANTX) (ANTX) raised $69 million in an IPO on Friday, March 25th 2022. The company issued 4,600,000 shares at $14.00-$16.00 per share.

What other stocks do shareholders of (ANTX) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Intel (INTC), CrowdStrike (CRWD), DocuSign (DOCU), Micron Technology (MU), Valero Energy (VLO), Pfizer (PFE) and Align Technology (ALGN).

This page (NYSE:ANTX) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners